61R Stock Overview
Euromedis Groupe, through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Euromedis Groupe Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.58 |
| 52 Week High | €5.84 |
| 52 Week Low | €3.91 |
| Beta | -0.50 |
| 1 Month Change | 3.85% |
| 3 Month Change | -14.23% |
| 1 Year Change | 15.08% |
| 3 Year Change | -81.27% |
| 5 Year Change | n/a |
| Change since IPO | -78.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| 61R | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 9.8% | -5.4% | -2.5% |
| 1Y | 15.1% | -6.2% | -0.4% |
Return vs Industry: 61R exceeded the German Medical Equipment industry which returned -6.2% over the past year.
Return vs Market: 61R exceeded the German Market which returned -0.4% over the past year.
Price Volatility
| 61R volatility | |
|---|---|
| 61R Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 61R has not had significant price volatility in the past 3 months.
Volatility Over Time: 61R's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 190 | Mathieu Roturier | www.euromedis.fr |
Euromedis Groupe, through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally. It offers sterile or non-sterile medical gloves, dressings and compresses, medical sets, parenteral approach, needles, syringes, infusers, catheters, etc.; and wound drainage products, probes, and a draping range for operating theaters, as well as surgical gloves and protective covers. The company also provides oxygen therapy; incontinence and various hygiene-related products; a range of diagnostics; and a range of home care products.
Euromedis Groupe Fundamentals Summary
| 61R fundamental statistics | |
|---|---|
| Market cap | €12.91m |
| Earnings (TTM) | -€5.51m |
| Revenue (TTM) | €49.54m |
0.3x
P/S Ratio-2.3x
P/E RatioIs 61R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 61R income statement (TTM) | |
|---|---|
| Revenue | €49.54m |
| Cost of Revenue | €33.34m |
| Gross Profit | €16.20m |
| Other Expenses | €21.71m |
| Earnings | -€5.51m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.98 |
| Gross Margin | 32.70% |
| Net Profit Margin | -11.12% |
| Debt/Equity Ratio | 40.5% |
How did 61R perform over the long term?
See historical performance and comparison